Catalyst Wire Dossier Catalyst Wire Dossier

Lencanizumab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lencanizumab, covering 2025-03-10 to 2025-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Conventional Symptomatic Drugs Combined with Lencanizumab in the Treatment of Early Alzheimer's Disease: a Multicenter, Prospective, Observational Study

See pricing